Last updated: July 28, 2025
Introduction
Patent CL2013001097, filed and granted in Chile, represents a significant element within the pharmaceutical patent landscape. Understanding its scope and claims is essential for stakeholders involved in licensing, generic entry, and strategic patent management. This analysis delineates the patent’s scope, examines its claims, and contextualizes its landscape within the broader regional and global pharmaceutical patent environment.
Patent Overview
Patent Number: CL2013001097
Application Date: Likely filed in 2013 (based on the number)
Grant Date: Pending or granted, precise date requires confirmation
Ownership: Proprietor details are not specified here but are available through the Chilean patent office records
Priority Date: Corresponds to the original filing date or earliest priority claim
The patent appears to relate to a specific pharmaceutical formulation or a method of treatment involving a particular compound or combination thereof, typical of drug patents filed in Chile. Chile's patent law extensively aligns with international standards, especially the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
Scope of the Patent
Scope Definition Through Claims
The scope of Chile patent CL2013001097 primarily hinges on its claims, which define the legal boundaries of patent protection. While the specific language of the claims is unavailable in this context, typical drug patents encompass:
- Compound Claims: Covering the chemical entity or a pharmaceutically active compound.
- Formulation Claims: Pertaining to specific compositions, excipient combinations, or delivery systems.
- Method of Use Claims: Describing the therapeutic methods or indications.
- Process Claims: Detailing manufacturing or synthesis methods.
In Chile, claims must be sufficiently clear and supported by the specification, conforming to patentability criteria of novelty, inventive step, and industrial applicability.
Likely Coverage
Given the common structure of pharmaceutical patents, the claims of CL2013001097 likely include:
- A novel chemical compound with specific structural features.
- A pharmaceutical composition comprising the compound, possibly with excipients.
- A method of treating specific medical conditions using the compound.
- Methods of synthesis or manufacturing protocols for the compound.
The patent’s scope may also extend to salts, polymorphs, or formulations thereof, especially if these provide improvements in stability, bioavailability, or efficacy.
Claim Analysis
Without the exact claims text, a typical examination considers:
1. Independent Claims
- Compound Claim: The core of the patent, defining the chemical structure with specific substituents, stereochemistry, or functional groups.
- Method Claim: Describing a particular therapeutic use or method of administration.
- Composition Claim: Covering the pharmaceutical formulation incorporating the compound.
2. Dependent Claims
- Refinements specifying particular embodiments—such as dosage forms, specific salts, or delivery devices.
- Claims tailored to manufacturing or purification processes.
Scope Interpretation
In Chile, claim scope is interpreted broadly but must be supported by the description. If the patent claims a compound, it may prevent others from manufacturing, using, or selling that compound, even if the specific use is not claimed.
Potential Limitations
- Prior art may limit the broader interpretation, especially if similar compounds or methods exist.
- Chile’s strict patentability standards require that claims represent a non-obvious and novel contribution, potentially narrowing scope if prior similar compounds exist.
Patent Landscape Context
Regional and International Landscape
Chile’s patent system aligns with international standards, but regional patent scope can be influenced by:
- Patent Cooperation Treaty (PCT): If filed via PCT, similar compounds or uses may already be claimed in other jurisdictions, impacting Chilean scope.
- Regional Patent Systems: Chile is part of the Andean Community, where regional patent harmonization influences scope and enforcement.
- Global Patent Strategies: Patent families filed in the United States, Europe, and Latin America can expand protection and influence freedom-to-operate considerations in Chile.
Patent Life Cycle and Enforcement
The patent’s life span, typically 20 years from filing, grants exclusivity within Chile, preventing competitors from producing or marketing the protected drug. Enforcement depends on local legal proceedings, with patent litigation being a critical venue for dispute resolution.
Status and Patent Validity
Recent patent invalidation or opposition actions could threaten its scope, especially if prior art emerged or legal challenges questioned its novelty or inventive step.
Challenges and Opportunities
-
Challenges:
- Patent cliffs due to expiry or invalidation.
- Launch of generic competitors post-expiry.
- Potential for narrow claims limiting scope, especially in complex compounds.
-
Opportunities:
- Broad formulation or use claims to extend protection.
- Patent strategies incorporating supplementary protection certificates (SPCs) or data exclusivity.
- Strategic licensing, especially if the patent covers a valuable therapeutic molecule.
Conclusion
Patent CL2013001097 primarily offers protection over a specific pharmaceutical entity or method, with scope centered on its claims’ language and supported description. Its strategic value depends on the scope’s breadth, enforceability, and interplay with regional and global patent landscapes. While Chile’s patent regime provides robust protection, the patent’s ultimate strength hinges on the clarity and novelty of its claims, as well as ongoing legal and market developments.
Key Takeaways
- The scope of Chile patent CL2013001097 likely encompasses a novel compound, formulation, or method of use, with the precise boundaries defined by its claims.
- Effective patent protection depends on broad, well-drafted claims supported by detailed description, especially given regional legal standards.
- The patent landscape involves regional considerations, including PCT filings and potential opposition or invalidation risks.
- Stakeholders should monitor patent expiry dates and legal challenges to inform market strategy and potential entry barriers.
- Diversification of patent protections through formulations, methods, or supplementary protections may extend market exclusivity.
FAQs
1. How does Chileian patent law influence the scope of pharmaceutical patents like CL2013001097?
Chile’s patent law requires claims to be clear, supported by the description, and to meet novelty and inventive step requirements, which directly shape the patent’s scope and enforceability.
2. Can the claims in CL2013001097 be amended post-grant?
Post-grant amendments are possible but are limited and must not enlarge the scope of the original claims. They typically require approval and are subject to legal standards.
3. How does the patent landscape in Chile compare to neighboring countries?
Chile’s patent system aligns closely with international standards, but differences in examination rigor and legal procedures can affect patent scope and enforceability relative to neighboring Latin American countries.
4. What strategies can companies use to navigate patent CL2013001097?
Options include designing around claims, filing for supplementary protection or data exclusivity, licensing, or challenging the patent’s validity if grounds exist.
5. When does patent CL2013001097 expire, and how does this impact market exclusivity?
Typically, pharmaceutical patents last 20 years from filing. The exact expiration date depends on the filing date; upon expiry, generic competition could enter the market, affecting profitability.
Sources:
- Chilean Patent and Trademark Office (INAPI).
- Chilean Law on Industrial Property (Ley N° 19.039).
- International Patent Documentation (WIPO, EPO, USPTO).
